Article Versions Notes

Pugliese N, Conti F, Rosato V, Gallo P, Gitto S, Riglietta M, Frigerio F, Perrone V, Veronesi C, Cappuccilli M, et al. Epidemiologic Characteristics Determining the Choice of Direct-Acting Antiviral Therapy in HCV Patients: An Italian Real-World Evidence Study. Pathogens. 2025; 14(11):1177. https://doi.org/10.3390/pathogens14111177

Pugliese, Nicola, Fabio Conti, Valerio Rosato, Paolo Gallo, Stefano Gitto, Marco Riglietta, Francesca Frigerio, Valentina Perrone, Chiara Veronesi, Maria Cappuccilli, and et al. 2025. "Epidemiologic Characteristics Determining the Choice of Direct-Acting Antiviral Therapy in HCV Patients: An Italian Real-World Evidence Study" Pathogens 14, no. 11: 1177. https://doi.org/10.3390/pathogens14111177

Pugliese, N., Conti, F., Rosato, V., Gallo, P., Gitto, S., Riglietta, M., Frigerio, F., Perrone, V., Veronesi, C., Cappuccilli, M., Degli Esposti, L., Mangia, A., & Kondili, L. A. (2025). Epidemiologic Characteristics Determining the Choice of Direct-Acting Antiviral Therapy in HCV Patients: An Italian Real-World Evidence Study. Pathogens, 14(11), 1177. https://doi.org/10.3390/pathogens14111177